Advanced and Metastatic NSCLC: Lessons From Patients Beyond the Classroom

Angela Christine Argento, MD


September 29, 2022

Angela Christine Argento, MD, weighs the relative benefits of formal education and practical experience in the development of personalized treatment for advanced non–small cell lung cancer.

Recalling positive experiences with various mentors, Dr Argento implores clinicians to talk to and listen to patients in order to understand their priorities and what they are hoping to gain from treatment. Doing so will provide the necessary framework for complete and optimal treatment.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.